Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.135
-0.165 (-5.00%)
At close: Jul 18, 2025, 4:00 PM
3.130
-0.005 (-0.16%)
After-hours: Jul 18, 2025, 4:20 PM EDT
Cytek Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts that cover Cytek Biosciences stock have a consensus rating of "Hold" and an average price target of $6, which forecasts a 91.39% increase in the stock price over the next year. The lowest target is $3 and the highest is $8.
Price Target: $6 (+91.39%)
Analyst Consensus: Hold
* Price targets were last updated on May 28, 2025.
Analyst Ratings
The average analyst rating for Cytek Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
Total | 3 | 2 | 2 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +123.29% | May 28, 2025 |
Goldman Sachs | Goldman Sachs | Strong Sell Maintains $3.5 → $3 | Strong Sell | Maintains | $3.5 → $3 | -4.31% | May 12, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $6 | Buy | Reiterates | $6 | +91.39% | Mar 19, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +155.18% | Mar 4, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $8 → $8.5 | Buy | Maintains | $8 → $8.5 | +171.13% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
202.27M
from 200.45M
Increased by 0.91%
Revenue Next Year
217.95M
from 202.27M
Increased by 7.75%
EPS This Year
-0.22
from -0.05
EPS Next Year
-0.16
from -0.22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 209.6M | 234.1M | 273.2M |
Avg | 202.3M | 218.0M | 248.9M |
Low | 192.1M | 196.7M | 228.7M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 4.6% | 15.8% | 25.4% |
Avg | 0.9% | 7.8% | 14.2% |
Low | -4.2% | -2.8% | 4.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.09 | -0.07 | -0.06 |
Avg | -0.22 | -0.16 | -0.10 |
Low | -0.31 | -0.21 | -0.14 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.